Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for BPSD in Dementia with Lewy Bodies
jRCTs041180125Completed
- Sponsor
- National Center for Geriatrics and Gerontology
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in dementia with Lewy bodies (DLB) and Dementia comparing Zonisamide 100 mg/day with Placebo (2 arms). Primary endpoint: Neuropsychiatric Inventory. Started Oct 2017; status: completed.
02
Drugs
zonisamide
03
Conditions
dementia with Lewy bodies (DLB)Dementia
Beyond the preview
Go deeper on jRCTs041180125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180125.